Intravenous Tirofiban After Delayed Thrombolysis in Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 852 participants.
Also called NCT07111806
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 852 participants
- Registry
-
NCT07111806
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07111806. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-01 (anticipated); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Tirofiban After Delayed Thrombolysis in Stroke
- Acronym
- PEARL-TIRO
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Placebo
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct07111806- Content hash
74bcaec8e796fe0af54c2cf728aebd14ca11c76aeea4d02f594e84530429f0b3